Abstract:Purpose In this study, we applied laser capture microdissection and a proteomic approach to identify novel nasopharyngeal carcinoma (NPC) biomarkers. Methods Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by two-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry. Expression of the differential protein cytokeratin 18 in the above two tissues as well as 4 NPC cell lines was determined by Western blotting. Immunohistochemistry was also performed to detect the expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated. siRNA and in vitro cell invasion assay were used to check the correlation between the expression of cytokeratin 18 and invasive ability of NPC. Results Thirty-six differential proteins between the NPC and NNET were identified. The expression level of cytokeratin 18 in the two types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines. Significant cytokeratin 18 down-regulation was observed in NPC versus NNET ( P = 0.000), whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis versus primary NPC ( P = 0.001). In addition, cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation ( P = 0.000), whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage ( P = 0.019), recurrence ( P = 0.000), and regional lymph node metastasis ( P = 0.001), and distant metastasis ( P = 0.000). And down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells. Furthermore, survival curves showed that patients with cytokeratin 18 up-regulation had a poor prognosis ( P = 0.000). Univariate analysis (Cox’s proportional hazards model) showed that WHO histologic type ( P = 0.025), lymph node metastasis ( P = 0.007), distant metastasis ( P = 0.005), recurrence ( P = 0.000), and cytokeratin 18 ( P = 0.000) were significantly associated with the prognosis of NPC. Multivariate analysis confirmed that lymph node metastasis ( P = 0.012), distant metastasis ( P = 0.009), recurrence ( P = 0.006), and cytokeratin 18 ( P = 0.001) were independent prognostic indicators. Conclusions The data suggest that cytokeratin 18 is a potential biomarker for the differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.

Increased Expression Of Flotillin-2 Protein As A Novel Biomarker For Lymph Node Metastasis In Nasopharyngeal Carcinoma

Author Correction: Flotillin-2 Promotes Metastasis of Nasopharyngeal Carcinoma by Activating NF-κB and PI3K/Akt3 Signaling Pathways

Upregulation of flotillin-1 promotes invasion and metastasis by activating TGF-β signaling in nasopharyngeal carcinoma.

Flot-2 Expression Correlates With Egfr Levels And Poor Prognosis In Surgically Resected Non-Small Cell Lung Cancer

The relationship between expression of lymph vessels and micro vessels in nasopharyngeal carinoma

Increased Expression Of Irs-1 Is Associated With Lymph Node Metastasis In Nasopharyngeal Carcinoma

Identification of Flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis

Lactotransferrin Could Be a Novel Independent Molecular Prognosticator of Nasopharyngeal Carcinoma

[Expression Clinical Significance of Nm23-H1 and Vessel Endothelium Growth Factor Protein in Nasopharyngeal Carcinoma].

Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.

Elevated Expression of Flotillin-1 is Associated with Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.

Proteomic Analysis to Identify Cytokeratin 18 As a Novel Biomarker of Nasopharyngeal Carcinoma

Transcriptional Patterns, Biomarkers and Pathways Characterizing Nasopharyngeal Carcinoma of Southern China

Epression and Significance of VEGF-C,COX-2 and VEGFR-3 in Nasopharyngeal Carcinoma

Expression and clinical significance of Wnt-1 and beta-catenin in nasopharyngeal carcinoma.

Expression of Programmed Death Ligand-2 is associated with Prognosis in Nasopharyngeal Carcinoma Microenviroment

Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma

Expression of Vascular Endothelial Growth Factor,basic Fibroblast Growth Factor and Their Correlation with Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma

Flotillin-2 is associated with breast cancer progression and poor survival outcomes

Detailed analysis of inflammatory cell infiltration and the prognostic impact on nasopharyngeal carcinoma